These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33876228)
1. The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL. Parikh SA; Rabe KG; Kay NE; Call TG; Ding W; Leis JF; Kenderian SS; Muchtar E; Wang Y; Koehler AB; Schwager SM; Lesnick CE; Kleinstern G; Van Dyke D; Hanson CA; Braggio E; Slager SL; Shanafelt TD Blood; 2021 Jul; 138(2):149-159. PubMed ID: 33876228 [TBL] [Abstract][Full Text] [Related]
2. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines. Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224 [TBL] [Abstract][Full Text] [Related]
3. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL). Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370 [TBL] [Abstract][Full Text] [Related]
4. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638 [TBL] [Abstract][Full Text] [Related]
6. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. Kleinstern G; O'Brien DR; Li X; Tian S; Kabat BF; Rabe KG; Norman AD; Yan H; Vachon CM; Boddicker NJ; Call TG; Parikh SA; Bruins L; Bonolo de Campos C; Leis JF; Shanafelt TD; Ding W; Cerhan JR; Kay NE; Slager SL; Braggio E Am J Hematol; 2020 Aug; 95(8):906-917. PubMed ID: 32279347 [TBL] [Abstract][Full Text] [Related]
7. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Kleinstern G; Boddicker NJ; O'Brien DR; Allmer C; Rabe KG; Norman AD; Griffin R; Yan H; Ma T; Call TG; Bruins L; Brown S; Bonolo de Campos C; Hanson CA; Leis JF; Ding W; Vachon CM; Kay NE; Oakes CC; Parker AS; Brander DM; Weinberg JB; Furman RR; Shanafelt TD; Cerhan JR; Parikh SA; Braggio E; Slager SL Blood Adv; 2024 May; 8(9):2118-2129. PubMed ID: 38359367 [TBL] [Abstract][Full Text] [Related]
8. The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring. Dagklis A; Fazi C; Sala C; Cantarelli V; Scielzo C; Massacane R; Toniolo D; Caligaris-Cappio F; Stamatopoulos K; Ghia P Blood; 2009 Jul; 114(1):26-32. PubMed ID: 19029437 [TBL] [Abstract][Full Text] [Related]
9. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485 [TBL] [Abstract][Full Text] [Related]
10. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis. D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398 [TBL] [Abstract][Full Text] [Related]
11. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis. Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470 [TBL] [Abstract][Full Text] [Related]
12. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype. Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144 [TBL] [Abstract][Full Text] [Related]
13. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia. Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403 [TBL] [Abstract][Full Text] [Related]
14. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients. Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919 [TBL] [Abstract][Full Text] [Related]
15. Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Abdelbaky SB; Giacopelli B; Rabe KG; Yamaguchi K; Wu YZ; Yan H; Shanafelt TD; Parikh SA; Ding W; Hampel PJ; Brown S; Cerhan JR; Vachon CM; Kay NE; Hanson CA; Parker AS; Braggio E; Slager SL; Oakes CC Blood; 2024 Apr; 143(17):1752-1757. PubMed ID: 38194687 [TBL] [Abstract][Full Text] [Related]
16. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis. Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771 [TBL] [Abstract][Full Text] [Related]
17. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes. Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173 [TBL] [Abstract][Full Text] [Related]
18. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Vardi A; Dagklis A; Scarfò L; Jelinek D; Newton D; Bennett F; Almeida J; Rodriguez-Caballero A; Allgood S; Lanasa M; Cortelezzi A; Orlandi E; Veronese S; Montillo M; Rawstron A; Shanafelt T; Orfao A; Stamatopoulos K; Ghia P Blood; 2013 May; 121(22):4521-8. PubMed ID: 23596047 [TBL] [Abstract][Full Text] [Related]